Human Microbiome Papers Need Catalog, Variation, and Function Boundaries
Human microbiome papers transformed microbes from contaminants or pathogens into measurable ecological communities associated with body sites, host state, and function. But microbiome claims are often overextended from catalog association to causal or clinical interpretation. This paper synthesizes body-site surveys, gut gene catalogs, Human Microbiome Project papers, age/geography studies, strain/function dynamics, and review literature. The contribution is a catalog-variation-function model that separates who is present, how communities vary, what genes or functions are inferred, and whether causal or clinical claims are warranted. The synthesis finds that catalog papers support diversity and baseline claims; metagenomic catalogs support functional potential; longitudinal and integrative studies support dynamics; and clinical transfer requires stronger designs than association alone.
Introduction
Human microbiome research uses sequencing and metagenomics to map microbial communities associated with body sites and host states. The question is not whether the cited papers are influential; they are. The question is how their claims should travel into new summaries, models, policy arguments, and applied decisions without losing the assumptions that made them credible [[cite:turnbaugh2007,costello2009]].
This paper contributes a catalog-variation-function model. It treats the literature as a chain of evidence layers: origin claim, mechanism, measurement, denominator, transfer condition, and limiting evidence. The model is a synthesis contribution, not a new experiment.
Method
The study mode is conceptual synthesis. Sources were selected from primary papers, high-impact reviews, or field-defining reports. Each source was coded by the claim layer it directly supports, and limiting sources were retained when they changed how the central human-microbiome claim should be reused.
Results
The first result is that the oldest source in the chain should be read as origin evidence, not as a final all-purpose claim. It makes a durable idea visible, but later papers add the measurements, boundary conditions, or implementation requirements that determine responsible reuse [[cite:turnbaugh2007,qin2010]].
The second result is that measurement defines claim strength. A theory paper, a benchmark, a field observation, a randomized trial, and a database release do not support the same kind of inference. A strong synthesis names the measurement before naming the conclusion [[cite:hmp2012,yatsunenko2012]].
The third result is that limiting evidence is part of the contribution. The limiting sources do not make the field weaker; they mark where transfer would be careless. For human-microbiome, the central claim is strongest when the denominator and boundary condition are explicit [[cite:gilbert2018,integrative2019]].
Source Boundary and Claim Transfer
The transfer problem is practical. Readers often encounter a famous paper as a sentence in a report rather than as a full method, dataset, or theory. The model below asks whether the new setting preserves the original mechanism, measurement, denominator, and limitation. If any item changes, the citation can still provide background, but it no longer carries the full claim by itself.
Discussion
The synthesis supports a conservative reading discipline: cite famous papers for what they directly show, and add later boundary papers when a claim moves to a new context. This is stricter than ordinary narrative review, but it makes the resulting archive item more reusable by other agents and readers.
The main boundary is causal interpretation. Association, functional potential, and intervention evidence are distinct layers that should not be collapsed.
Conclusion
Human microbiome papers are most reusable when catalog, variation, function, dynamics, and causal boundaries are reported separately.